Assessing a multicomponent quality improvement strategy for chronic care of cardiovascular diseases in India: The C-QIP randomized feasibility trial

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

by Kavita Singh, Ambuj Roy, Dimple Kondal, Kalyani Nikhare, Mareesha Gandral, Satish G. Patil, Kiran Aithal, M. P. Girish, Mohit Gupta, Kushal Madan, J. P. S.

Sawhney, Kamar Ali, Meetushi Jain, Savitesh Kushwaha, Devraj Jindal, Emily Mendenhall, Shivani A. Patel, K. M. Venkat Narayan, Nikhil Tandon, Mark D. Huffman, Dorairaj Prabhakaran Background Chronic cardiovascular diseases (CVD) care quality remains suboptimal, globally. We assessed the feasibility, acceptability, fidelity, and preliminary effect of a multicomponent, collaborative quality improvement (C-QIP) strategy among patients with CVD…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: PLOS Medicine · September 29, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.